Biotech (new drugs) stocks

바이오 신약

What are Biotech (new drugs) stocks in Korea?

The Biotech (new drugs) theme on jonbur groups 190 Korean stocks listed on KOSPI and KOSDAQ, worth ₩212T in total. On Oct 30, 2026 the group moved up 2.36% (weighted by market value); the largest members are Samsung Biologics, Celltrion, Alteogen.

Stocks: 190
Total market value: ₩212T
Day's move: +2.36%
As of: Oct 30, 2026
Largest members: Samsung Biologics, Celltrion, Alteogen

Earnings tracker · 3Q 2025

Past quarter

171 of 194 reportedOperating profit up vs a year ago: 88 of 156

Revenue+17.0%

Operating profit+97.5%

Net profit+179.2%

Combined, for the companies that have reported, vs the same quarter a year ago

Company	Reported	Revenue	vs a year ago	Operating profit	vs a year ago	vs last quarter	Op. margin
Samsung Biologics	Nov 14	₩1.7T	+39.9%	₩729B	+115.3%	+53.2%	43.9%28.5%
Celltrion	Nov 14	₩1T	+16.7%	₩301B	+45.1%	+24.3%	29.3%23.5%
Alteogen	Nov 14	₩49B	+902.3%	₩27B	Turned to profit	Turned to profit	54.4%−166.8%
SK biopharmaceuticals	Nov 14	₩192B	+40.4%	₩70B	+262.4%	+13.3%	36.6%14.2%
Yuhan	Nov 14	₩570B	−4.8%	₩22B	−53.7%	−55.8%	3.9%7.9%
HLB	Nov 14	₩22B	+30.4%	−₩23B	Bigger loss	Smaller loss	−104.1%−115.4%
Hanmi Pharm	Nov 14	₩362B	+0.1%	₩55B	+8.0%	−8.9%	15.2%14.1%
SK Bioscience	Nov 13	₩151B	+144.6%	−₩19B	Smaller loss	Smaller loss	−12.8%−64.3%
LigaChem Biosciences	Nov 14	₩41B	+36.1%	−₩23B	Turned to loss	Bigger loss	−56.0%1.7%
Hugel	Nov 14	₩106B	+0.8%	₩47B	−11.2%	−16.4%	44.8%50.8%
PharmaResearch	Nov 14	₩135B	+51.8%	₩62B	+77.2%	+10.7%	45.7%39.1%
ABL Bio	Nov 11	₩1.4B	−81.8%	−₩22B	Bigger loss	Turned to loss	−1,552.8%−185.1%
Peptron	Nov 14	₩1.6B	+172.3%	−₩6.2B	Bigger loss	Bigger loss	−389.3%−798.9%
OliX Pharmaceuticals	Nov 14	₩2.9B	+1,002.6%	−₩8.3B	Smaller loss	Bigger loss	−285.7%−3,580.1%
Voronoi	Nov 14	₩4.1B	Turned to profit	−₩14B	Bigger loss	Bigger loss	−327.6%
Hanall Biopharma	Nov 14	₩41B	+10.8%	₩349M	−18.9%	−69.6%	0.9%1.2%
Caregen	Nov 14	₩17B	−15.9%	₩9.9B	−22.2%	+32.6%	57.7%62.4%
Mezzion Pharma	Nov 14	₩2.1B	−5.9%	−₩4.7B	Bigger loss	Bigger loss	−218.6%−73.4%
Seegene	Nov 14	₩114B	+4.3%	₩9.6B	+82.8%	+205.6%	8.5%4.8%
GC Biopharma	Nov 14	₩609B	+31.1%	₩29B	−26.2%	+6.7%	4.8%8.5%
ST Pharm	Nov 14	₩82B	+32.7%	₩15B	+141.6%	+14.0%	18.0%9.9%
Naturecell	Nov 14	₩3.9B	−33.0%	−₩1.4B	Bigger loss	Bigger loss	−35.7%−17.0%
OSCOTECInc	Nov 12	₩8.9B	−69.2%	−₩373M	Turned to loss	Smaller loss	−4.2%67.6%
Kolon TissueGene	Nov 14	₩1.2M	−21.7%	−₩2.5M	Smaller loss	Smaller loss	−208.4%−276.8%
Daewoong Pharma	Nov 14	₩412B	+14.9%	₩57B	+52.6%	−1.7%	13.8%10.4%
Daewoong	Nov 14	₩542B	+5.1%	₩81B	−20.8%	−5.6%	14.9%19.7%
Chong Kun Dang Pharmaceutical	Nov 14	₩430B	+4.1%	₩21B	−19.4%	−11.2%	4.9%6.3%
JS Link	Nov 14	₩5.2B	+26.4%	−₩3.9B	Bigger loss	Bigger loss	−74.8%−60.6%
L&C Bio	Nov 14	₩23B	+21.6%	₩2.9B	+1,556.4%	Turned to profit	12.8%0.9%
Chabiotech	Nov 13	₩319B	+17.2%	−₩8.1B	Bigger loss	Smaller loss	−2.5%−2.5%
Qurient	Nov 14	₩1.7B	−25.3%	−₩7B	Bigger loss	Bigger loss	−415.4%−266.0%
Proteina	Nov 14	₩582M	—	−₩2.9B	—	—	−506.4%
Rznomics	Nov 11	₩0	—	−₩8.1B	Bigger loss	Turned to loss	—
G2GBIO	Nov 13	₩58M	—	−₩3.6B	—	Bigger loss	−6,098.1%
Pharmicell	Nov 13	₩26B	+75.7%	₩8.1B	+533.9%	−0.3%	31.7%8.8%
Onconic Therapeutics	Nov 11	₩19B	—	₩8.3B	—	+647.3%	43.3%
Hyundai Bioscience	Nov 14	₩553M	+20.6%	−₩4.6B	Bigger loss	Smaller loss	−835.3%−722.7%
Medy-Tox	Nov 13	₩61B	+13.3%	₩8.9B	+48.3%	+40.9%	14.6%11.1%
Shinpoong Pharmaceutical	Nov 14	₩63B	+12.2%	₩7.2B	Turned to profit	+46.2%	11.5%−0.3%
GI Innovation	Nov 14	₩0	Flat	−₩11B	Smaller loss	Smaller loss	—
HLB Pharmaceutical	Nov 14	₩61B	+74.3%	₩34M	−96.0%	Turned to profit	0.1%2.5%
HLB Life Science	Nov 14	₩14B	−47.9%	−₩3.8B	Smaller loss	Smaller loss	−28.2%−23.3%
IL Dong Pharmaceutical	Nov 13	₩145B	−6.7%	₩6.8B	+87.6%	+1,033.9%	4.6%2.3%
GemVax & KAEL	Nov 14	₩18B	+41.2%	₩735M	Turned to profit	Turned to profit	4.1%−69.6%
Penetrium Bioscience	Nov 14	₩2.6B	+29.0%	−₩1.5B	Smaller loss	Smaller loss	−55.8%−115.3%
AbClon	Nov 10	₩1.6B	+96.3%	−₩3.5B	Bigger loss	Bigger loss	−225.9%−408.2%
Bukwang Pharmaceutical IND	Nov 14	₩48B	+12.2%	₩979M	−69.2%	−51.4%	2.0%7.5%
Curocell	Nov 13	₩0	Flat	−₩9.2B	Smaller loss	Smaller loss	—
Orum Therapeutics	Nov 14	₩16M	—	−₩14B	—	Bigger loss	−87,721.7%
Dong-A ST	Nov 14	₩216B	+12.8%	₩14B	+221.9%	Turned to profit	6.5%2.3%
AprilBio	Nov 13	₩0	Flat	−₩2.5B	Bigger loss	Smaller loss	—
Medipostco	Nov 14	₩19B	+8.2%	−₩14B	Smaller loss	Smaller loss	−75.3%−84.4%
ToolGen	Nov 14	₩631M	+42.9%	−₩5.4B	Bigger loss	Smaller loss	−858.5%−1,149.2%
EuBiologics	Nov 10	₩41B	+13.7%	₩19B	+11.4%	+68.2%	46.0%47.0%
SillaJen	Nov 14	₩2.8B	+114.2%	−₩6.1B	Smaller loss	Smaller loss	−222.0%−589.3%
NKGen Biotech Korea	Nov 14	₩2.2B	−5.4%	₩44M	Turned to profit	Turned to profit	2.0%−59.4%
Q AID	Nov 14	₩26B	−21.3%	−₩1B	Smaller loss	Turned to loss	−4.0%−3.4%
Genomictree	Nov 14	₩897M	+29.3%	−₩3.4B	Smaller loss	Bigger loss	−384.0%−560.4%
Prestige BioPharma	Nov 28	−₩826,582	Smaller loss	−₩7.1M	Smaller loss	Smaller loss	—
S.Biomedics	Nov 14	₩3.2B	−3.9%	−₩1.9B	Bigger loss	Smaller loss	−59.4%−39.4%
HLB Therapeutics	Nov 14	₩16B	+14.3%	−₩5.4B	Bigger loss	Bigger loss	−33.5%−13.0%
ImmuneOncia Therapeutics	Nov 14	₩0	—	−₩11B	—	—	—
IntoCell	Nov 14	₩1.4B	+44.4%	−₩1.3B	Smaller loss	Smaller loss	−91.3%−234.8%
GC Genome	Nov 14	₩8.8B	—	₩773M	—	—	8.7%
FutureChem	Nov 14	₩3.8B	−9.4%	−₩2.5B	Bigger loss	Bigger loss	−66.7%−56.0%
BioPlus	Nov 14	₩24B	+46.5%	₩4.9B	+3.3%	+135.9%	20.3%28.7%
Binex	Nov 14	₩45B	+37.8%	₩242M	Turned to profit	−76.3%	0.5%−14.3%
Genome&Company	Nov 14	₩6.6B	+41.9%	−₩8.1B	Bigger loss	Bigger loss	−123.4%−169.8%
Vivozon Pharmaceutical	Nov 10	₩6.8B	−71.4%	−₩10B	Turned to loss	Bigger loss	−151.0%5.4%
curacle	Nov 14	—	—	−₩2.9B	Smaller loss	Smaller loss	—
Kangstem Biotech	Nov 13	₩485M	−38.1%	−₩4.2B	Bigger loss	Smaller loss	−864.6%−508.5%
Bioneercorporation	Nov 14	₩88B	+33.7%	₩2.9B	Turned to profit	−45.5%	3.3%−12.4%
DuChemBio	Nov 13	₩9.9B	—	₩1.9B	—	+0.7%	19.2%
Helixmith	Nov 14	₩565M	−68.7%	−₩2.7B	Smaller loss	Bigger loss	−474.0%−280.5%
3billion	Nov 13	₩3.2B	—	−₩1.3B	—	Smaller loss	−39.3%
Eone Diagnomics Genome Center	Nov 14	₩1.8B	−77.1%	−₩415M	Smaller loss	Turned to loss	−23.2%−24.7%
Kolon Life Science	Nov 14	₩66B	+85.1%	₩19B	Turned to profit	+1,403.2%	28.4%−25.0%
BNC Korea	Nov 14	₩22B	−5.2%	−₩1.4B	Turned to loss	Turned to loss	−6.3%14.5%
GC Cell	Nov 14	₩45B	−0.7%	−₩397M	Smaller loss	Smaller loss	−0.9%−6.0%
Cellbion	Nov 14	₩679M	—	−₩2B	—	Smaller loss	−294.1%
Aptabio Therapeutics	Nov 14	₩1.2B	+38.7%	−₩3.4B	Smaller loss	Smaller loss	−283.3%−687.0%
ISU Abxis	Nov 14	₩16B	+79.5%	₩562M	+287.3%	−94.0%	3.6%1.7%
Bio Solution	Nov 14	₩4.5B	+31.4%	−₩1.1B	Smaller loss	Smaller loss	−24.4%−36.6%
Cell Biotech	Nov 14	₩15B	+26.3%	₩2.2B	+6.1%	+72.9%	14.4%17.2%
Aribio Holdings	Nov 14	₩7.9B	−51.1%	−₩2.4B	Bigger loss	Smaller loss	−30.9%−5.0%
Y-Biologics	Nov 14	₩892M	−72.5%	−₩2.5B	Bigger loss	Bigger loss	−283.5%−5.8%
Anterogen	Nov 14	₩2B	+7.4%	−₩407M	Smaller loss	Smaller loss	−19.9%−33.6%
Ilyang Pharmaceutical	Nov 13	₩69B	−30.6%	−₩158M	Turned to loss	Turned to loss	−0.2%5.5%
JW Shinyak	Nov 14	₩21B	−34.7%	₩2.7B	−66.8%	+0.8%	13.1%25.8%
Macrogen	Nov 14	₩49B	+48.7%	₩1.1B	Turned to profit	Turned to profit	2.3%−1.8%
TiumBio	Nov 14	₩3.1B	+175.8%	−₩4.5B	Bigger loss	Bigger loss	−144.8%−387.7%
MedPacto	Nov 12	₩1.2B	Turned to profit	−₩4.7B	Bigger loss	Bigger loss	−395.4%
Celemics	Nov 14	₩1.3B	−7.2%	−₩1.1B	Bigger loss	Smaller loss	−85.4%−35.6%
Keeps Biopharma	Nov 14	₩41B	+29.8%	₩1.4B	+42.0%	Turned to profit	3.5%3.2%
Asta	Nov 14	₩1.1B	+174.7%	−₩504M	Smaller loss	Turned to loss	−47.5%−212.6%
Genexine	Nov 13	₩3B	+1,355.9%	−₩7.4B	Smaller loss	Smaller loss	−243.6%−4,903.8%
DreamCIS	Nov 13	₩17B	−9.2%	₩2.8B	+91.3%	+84.4%	16.9%8.0%
Aribiolab	Nov 13	₩0	Flat	−₩3.4B	Bigger loss	Bigger loss	—
ViGenCell	Nov 13	₩8M	+1,500.2%	−₩2.4B	Smaller loss	Smaller loss	−30,405.0%−723,543.9%
HLB bioStep	Nov 14	₩24B	+29.3%	₩455M	Turned to profit	Turned to profit	1.9%−14.4%
Aminologics	Nov 14	₩6B	+150.9%	₩1.4B	Turned to profit	+549.4%	23.4%−88.9%
HLB Global	Nov 14	₩27B	+29.6%	−₩84M	Smaller loss	Smaller loss	−0.3%−16.1%
T&R Biofab	Dec 1	₩7B	+534.1%	−₩1.3B	Smaller loss	Smaller loss	−18.2%−279.2%
Vaxcell-Bio Therapeutics	Nov 14	₩1.7B	+3,580.6%	−₩3.4B	Smaller loss	Smaller loss	−208.1%−7,889.0%
Corestemchemon	Nov 14	₩3.6B	−56.7%	−₩7.5B	Bigger loss	Bigger loss	−208.0%−68.5%
iNtRON Biotechnology	Nov 14	₩1.6B	+34.3%	−₩2.1B	Bigger loss	Bigger loss	−127.2%−135.3%
Cellumed	Nov 14	₩37B	+12.0%	₩1.4B	Turned to profit	Turned to profit	3.9%−3.7%
Enzychem Lifesciences	Nov 14	₩16B	−3.2%	−₩3.7B	Bigger loss	Bigger loss	−22.6%−15.7%
Choong ANG Vaccine Laboratory	Nov 14	₩11B	+2.4%	₩1.5B	−9.5%	+3.2%	14.1%16.0%
HLB Genex	Nov 14	₩10B	+11.3%	−₩384M	Bigger loss	Turned to loss	−3.8%−0.5%
SCL Science	Nov 14	₩7B	+594.8%	₩169M	Turned to profit	Turned to profit	2.4%−77.9%
GC Medical Science	Nov 14	₩26B	−1.8%	₩944M	+1.3%	−10.8%	3.6%3.5%
Eye Gene	Nov 10	₩1.1B	+14.4%	−₩1.6B	Smaller loss	Smaller loss	−150.1%−375.3%
Theragen Etex	Nov 14	₩69B	+14.5%	₩2B	−31.5%	Turned to profit	2.8%4.8%
Daebonglsco	Nov 14	₩25B	+2.5%	₩768M	−75.7%	−67.3%	3.1%13.0%
Choolip & Sciences	Nov 14	₩544M	+493.9%	−₩2.1B	Bigger loss	Bigger loss	−381.6%−1,617.7%
Pharos iBio	Nov 11	—	—	−₩3B	Smaller loss	Bigger loss	—
Sugentech	Nov 14	₩1.5B	−63.9%	−₩4.8B	Bigger loss	Smaller loss	−326.6%−107.6%
DongKook Life Science	Nov 13	₩29B	—	₩4.3B	—	+33.1%	14.5%
Amicogen	Nov 14	₩10B	−74.6%	−₩4.7B	Bigger loss	Bigger loss	−46.1%−3.4%
CG Invites	Nov 14	₩6.1B	+276.2%	−₩6.9B	Bigger loss	Smaller loss	−112.4%−239.6%
SunBio	Nov 13	₩4.2B	+132.8%	₩1.6B	Turned to profit	+1,269.4%	38.2%−7.8%
PharmGen Science	Nov 14	₩42B	−0.4%	₩1.4B	−55.1%	−58.6%	3.3%7.3%
Optipharm	Nov 14	₩5.7B	+18.6%	−₩525M	Smaller loss	Bigger loss	−9.2%−11.4%
Abion	Oct 31	₩162M	+6.7%	−₩4.4B	Smaller loss	Bigger loss	−2,711.3%−5,309.3%
Adbiotech	Nov 14	₩3.6B	+109.3%	−₩1.8B	Bigger loss	Smaller loss	−48.5%−64.6%
Pangen Biotech	Nov 13	₩4B	−12.7%	₩377M	−71.7%	−54.7%	9.4%29.0%
HLB Panagene	Nov 14	₩3.6B	−5.6%	−₩829M	Bigger loss	Bigger loss	−22.8%−6.7%
Tego Science	Nov 14	₩1.6B	−18.3%	−₩955M	Bigger loss	Bigger loss	−59.0%−7.5%
NeoImmuneTech	Nov 7	₩12,976	−98.4%	−₩3.2M	Smaller loss	Smaller loss	−24,577.2%−1,053.9%
Cytogen	Nov 13	₩7.6B	+128.5%	−₩1.3B	Smaller loss	Smaller loss	−17.2%−65.5%
KoBioLabs	Nov 13	₩19B	+13.9%	−₩423M	Smaller loss	Smaller loss	−2.2%−7.7%
ENCell	Nov 14	₩1.5B	—	−₩3.7B	—	Smaller loss	−240.8%
GeneOne Life Science	Nov 14	₩5.1B	−42.9%	−₩12B	Bigger loss	Bigger loss	−229.7%−116.7%
CJ Bioscience	Nov 14	₩738M	−0.8%	−₩6.1B	Smaller loss	Smaller loss	−823.7%−1,150.7%
Aprogen	Nov 14	₩36B	−3.4%	−₩22B	Bigger loss	Smaller loss	−62.7%−59.9%
Geninus	Nov 14	₩2.2B	+21.9%	−₩2.3B	Bigger loss	Smaller loss	−108.3%−117.8%
Inbiogen	Nov 14	₩2.1B	+3.2%	−₩1.1B	Smaller loss	Bigger loss	−49.1%−61.7%
Gencurix	Nov 12	₩1.7B	+22.1%	−₩1.6B	Bigger loss	Bigger loss	−94.4%−104.3%
Quratis	Nov 14	₩507M	+468.4%	−₩2.2B	Smaller loss	Smaller loss	−425.7%−4,223.9%
RPbio	Nov 14	₩33B	+18.2%	₩273M	Turned to profit	−88.2%	0.8%−4.5%
Aprogen Biologics	Nov 13	₩21B	+45.3%	−₩11B	Smaller loss	Smaller loss	−50.5%−90.4%
Green Lifescience	Nov 14	₩11B	+155.1%	₩105M	Turned to profit	+717.9%	0.9%−14.1%
Wonbiogen	Nov 13	₩9.2B	+34.3%	₩2.4B	+42.7%	+26.7%	26.0%24.5%
Oncocross	Nov 14	₩29M	−84.0%	−₩2.4B	Bigger loss	Bigger loss	−8,104.5%−808.7%
HLB Pep	Nov 14	₩1.2B	+5.2%	−₩1.4B	Smaller loss	Bigger loss	−119.3%−129.1%
Kainos Medicine	Nov 14	₩322M	+58.2%	−₩1.5B	Smaller loss	Bigger loss	−467.3%−1,177.9%
Organoidsciences	Nov 14	₩320M	—	−₩3.9B	—	—	−1,220.5%
Eutilex	Nov 13	₩3.5B	−9.4%	−₩3.8B	Smaller loss	Smaller loss	−108.6%−178.4%
Orientbio	Nov 14	₩8.6B	−4.0%	−₩1.6B	Smaller loss	Bigger loss	−18.2%−19.4%
Kolmar BioTech	Nov 14	₩9.8B	+5.7%	−₩874M	Turned to loss	Smaller loss	−9.0%6.7%
SeouLin Bioscience	Nov 14	₩23B	+33.5%	₩785M	+415.8%	Turned to profit	3.4%0.9%
Genolution	Nov 14	₩2.1B	+22.4%	−₩2.4B	Smaller loss	Bigger loss	−117.9%−147.8%
Hass	Nov 14	₩4.8B	+44.2%	₩305M	Turned to profit	−68.4%	6.3%−5.4%
Biotoxtech	Nov 13	₩12B	+7.0%	−₩1.4B	Smaller loss	Smaller loss	−11.5%−18.3%
LabGenomics	Nov 14	₩23B	+6.4%	−₩2.1B	Smaller loss	Smaller loss	−9.2%−17.6%
SLSBio(Specialty Lab Solution Bio)	Nov 14	₩296M	−86.0%	−₩1.8B	Turned to loss	Bigger loss	−608.8%5.1%
Genematrix	Nov 14	₩2.6B	−1.7%	−₩109M	Smaller loss	Bigger loss	−4.2%−5.6%
C&R Research	Nov 14	₩16B	−4.0%	₩246M	−90.5%	−80.5%	1.6%15.8%
GFC Life Science	Nov 14	₩4.2B	—	−₩284M	—	—	−6.8%
Daesung Microbiological Labs	Nov 10	₩7.2B	+23.5%	₩591M	Turned to profit	−18.8%	8.2%−16.2%
MFC	Nov 14	₩4.5B	—	₩706,584	—	−99.9%	0.0%
WooGene B&Gco	Nov 14	₩13B	+13.1%	−₩769M	Bigger loss	Turned to loss	−5.8%−1.1%
Jeonjinbio	Nov 14	₩4.5B	−15.2%	₩326M	−35.2%	+277.6%	7.3%9.6%
Xcell Therapeutics	Nov 14	₩335M	−26.9%	−₩2.4B	Smaller loss	Smaller loss	−709.9%−590.5%
PeopleBio	Nov 14	₩1.2B	+23.2%	−₩2.1B	Smaller loss	Bigger loss	−174.6%−347.9%
Celestra	Nov 14	₩1.1B	−7.5%	−₩1.9B	Smaller loss	Smaller loss	−174.4%−551.7%
Olipass	Nov 11	₩124M	−82.4%	−₩1.5B	Smaller loss	Smaller loss	−1,246.6%−252.1%
From Bio	Nov 14	₩18B	+27.0%	−₩4.4B	Bigger loss	Bigger loss	−24.3%−29.8%
BioInfra	Nov 14	₩5.1B	—	−₩2.1B	—	Bigger loss	−40.5%
MOA Life Plus	Nov 14	₩1.2B	−66.6%	−₩1.5B	Bigger loss	Bigger loss	−124.4%−17.0%
072520	Not yet
208340	Not yet
QuadMedicine	Not yet
Aimed Bio	Not yet
Ingenia Therapeutics	Not yet
Samyang Biopharm	Not yet
Ensol Biosciences	Not yet
Kanaph Therapeutics	Not yet
Inventera	Not yet
HL Genomics	Not yet
NovMetaPharma	Not yet
Epi Biotech	Not yet
ProGen	Not yet
Plumbline Life Sciences	Not yet
Moogene Medi	Not yet
Curachem	Not yet
Invites Biocore	Not yet
Median Diagnostics	Not yet
Cronex	Not yet
BioInfra Life Science	Not yet
283100	Not yet
341170	Not yet
258540	Not yet

Single-quarter figures. Preliminary figures are the company's own early numbers and are replaced by the quarterly report when it's filed. Expected dates are around when each company reported a year ago.

Technical breadth

After the close on Oct 30, 2026

Above 20-day average: 8%
Above 60-day average: 17.3%
RSI above 70: 0.6%
RSI below 30: 14.8%
52-week highs: 0
52-week lows: 27

Index gauge · Short term

Bearish

0 bullish, 2 neutral, 7 bearish

Index gauge · Medium term

Bearish

0 bullish, 1 neutral, 7 bearish

Technical read

The Biotech (new drugs) theme covers 162 members, and only 8 percent of them sit above their 20-day average while 17.3 percent are above their 60-day average. Across the group, 0 stocks are at 52-week highs and 27 are at 52-week lows, with RSI readings running from an extreme low of 14.8 to a high of 0.6. The equal-weighted member index is labeled bearish on both the short and medium horizons, with its RSI at 32.6 and its price positioned below the cloud.

Written by AI from the indicator values above. Not advice.

Share of members, from each member's own indicators; the gauge reads an equal-weighted index of the members. Technical indicators describe past price and volume patterns. They are not predictions or recommendations.

Credit & macro

MaturitiesOct 23, 202685ISU Abxis: ₩50bn of bonds due in the next 6 months vs ₩23bn cash₩50bn due within 12 months, from the bond filings so far; cash and cash equivalents as of 2026 H1.ISU Abxis
MaturitiesOct 23, 202685GC Biopharma: ₩130bn of bonds due in the next 6 months vs ₩42bn cash₩130bn due within 12 months, from the bond filings so far; cash and cash equivalents as of 2026 H1.GC Biopharma
MaturitiesOct 20, 202685SK Reit: ₩130bn of bonds due in the next 6 months vs ₩54bn cash₩350bn due within 12 months, from the bond filings so far; cash and cash equivalents as of 2025 FY.SK Reit SK hynix SK Networks SK Discovery SKC SK Telecom

ETFs for this theme

All ETFs →

AUM · Flow 1w

Creators talking about this

Doctors begin to prescribe country’s first domestically developed obesity drug on Thurs.Arirang News · via YouTube

Biotech (new drugs)

−1.71%

바이오 신약

The Biotech (new drugs) theme in Korea covers companies that research, develop, and commercialize novel pharmaceutical drugs, including small-molecule compounds, biologics, and next-generation therapies such as antibody and cell treatments. Korean investors often group these firms together because they share a long development timeline, heavy R&D spending, and milestones tied to clinical trials, regulatory approvals, and licensing deals with global pharmaceutical companies. The theme is distinct from generic drug manufacturers and from contract manufacturing businesses, though some companies operate in several of these areas.

190 companies · 36 up · 22 flat · 132 down

Traded value: ₩781B
Value vs 20-day average: 0.88×
Top gainer: NovMetaPharma
Largest company: Samsung Biologics

Companies in this theme

Market cap Value traded Gainers Losers NPS stake

All KOSPI KOSDAQ

NPS owns > 5%

Company	Price	Daily	Traded value	Market cap	NPS
Samsung Biologics207940 · KOSPI	₩1,487,000	+8.86%	₩144B	₩69T	6.88%
Celltrion068270 · KOSPI	₩191,600	+1.22%	₩100B	₩44T	7.28%
Alteogen196170 · KOSDAQ	₩211,500	−3.86%	₩71B	₩15T	2.68%
SK biopharmaceuticals326030 · KOSPI	₩77,700	−0.13%	₩12B	₩6.1T	6.00%
Yuhan000100 · KOSPI	₩75,100	+0.54%	₩20B	₩5.5T	6.83%
HLB028300 · KOSDAQ	₩40,000	+0.76%	₩30B	₩5.3T	1.16%
Hanmi Pharm128940 · KOSPI	₩415,000	+6.82%	₩103B	₩5.3T	9.61%
SK Bioscience302440 · KOSPI	₩32,750	+1.71%	₩2.9B	₩2.6T	5.50%
LigaChem Biosciences141080 · KOSDAQ	₩61,500	−3.91%	₩8.6B	₩2.3T	4.99%
Hugel145020 · KOSDAQ	₩179,800	−1.91%	₩6.4B	₩2.3T	2.29%
PharmaResearch214450 · KOSDAQ	₩212,000	−4.72%	₩17B	₩2.2T	7.14%
ABL Bio298380 · KOSDAQ	₩39,200	−4.39%	₩11B	₩2.2T	4.02%
Peptron087010 · KOSDAQ	₩92,300	−5.04%	₩14B	₩2.2T	1.63%
OliX Pharmaceuticals226950 · KOSDAQ	₩94,000	−2.59%	₩15B	₩2.2T	5.04%
Voronoi310210 · KOSDAQ	₩106,100	−7.90%	₩9.3B	₩2T	2.78%
Hanall Biopharma009420 · KOSPI	₩37,500	−0.79%	₩5B	₩2T	10.56%
Caregen214370 · KOSDAQ	₩33,150	−2.36%	₩2B	₩1.8T	0.65%
Mezzion Pharma140410 · KOSDAQ	₩51,200	−2.66%	₩4.8B	₩1.6T	0.50%
Seegene096530 · KOSDAQ	₩33,250	−1.04%	₩5.6B	₩1.6T	0.64%
GC Biopharma006280 · KOSPI	₩130,200	−1.36%	₩3.2B	₩1.5T	6.68%
ST Pharm237690 · KOSDAQ	₩72,500	−2.03%	₩8.5B	₩1.5T	5.77%
Naturecell007390 · KOSDAQ	₩21,800	−1.80%	₩2.7B	₩1.4T	0.44%
OSCOTECInc039200 · KOSDAQ	₩36,450	−0.14%	₩4.5B	₩1.4T	3.87%
Aimed Bio0009K0 · KOSDAQ	₩18,860	−4.99%	₩3.1B	₩1.2T	0.03%
Kolon TissueGene950160 · KOSDAQ	₩13,920	−2.66%	₩3.3B	₩1.2T	0.57%
Daewoong Pharma069620 · KOSPI	₩101,100	−0.39%	₩3.1B	₩1.2T	10.30%
Ingenia Therapeutics950260 · KOSDAQ	₩22,350	−4.89%	₩3.2B	₩1.1T	—
Daewoong003090 · KOSPI	₩15,110	+1.41%	₩934M	₩879B	3.25%
Chong Kun Dang Pharmaceutical185750 · KOSPI	₩63,100	+0.96%	₩1.5B	₩871B	6.34%
JS Link127120 · KOSDAQ	₩18,230	−5.05%	₩3.4B	₩682B	5.05%
L&C Bio290650 · KOSDAQ	₩23,950	−4.58%	₩5.5B	₩646B	1.28%
Chabiotech085660 · KOSDAQ	₩6,750	−0.15%	₩1B	₩628B	0.31%
Qurient115180 · KOSDAQ	₩16,590	−6.95%	₩1.4B	₩623B	3.88%
Proteina468530 · KOSDAQ	₩54,300	+0.74%	₩13B	₩603B	3.78%
Rznomics476830 · KOSDAQ	₩21,300	−5.96%	₩6.4B	₩600B	3.96%
G2GBIO456160 · KOSDAQ	₩35,600	−2.73%	₩8B	₩592B	2.41%
Pharmicell005690 · KOSPI	₩9,400	−4.08%	₩4.4B	₩564B	2.38%
Onconic Therapeutics476060 · KOSDAQ	₩12,110	−4.04%	₩2B	₩550B	—
Hyundai Bioscience048410 · KOSDAQ	₩5,370	−5.29%	₩6B	₩518B	0.37%
Medy-Tox086900 · KOSDAQ	₩63,900	−0.47%	₩624M	₩466B	1.44%
Shinpoong Pharmaceutical019170 · KOSPI	₩8,350	−0.71%	₩2.1B	₩438B	0.39%
GI Innovation358570 · KOSDAQ	₩6,730	−3.03%	₩2.3B	₩434B	4.07%
HLB Pharmaceutical047920 · KOSDAQ	₩9,500	−0.11%	₩9.5B	₩414B	—
HLB Life Science067630 · KOSDAQ	₩3,295	+0.46%	₩489M	₩402B	0.07%
IL Dong Pharmaceutical249420 · KOSPI	₩12,580	+0.08%	₩6.7B	₩398B	2.30%
GemVax & KAEL082270 · KOSDAQ	₩8,650	−4.42%	₩1.3B	₩393B	2.55%
Penetrium Bioscience187660 · KOSDAQ	₩6,100	−1.13%	₩3.1B	₩390B	—
AbClon174900 · KOSDAQ	₩18,470	−5.81%	₩5.4B	₩369B	3.57%
Bukwang Pharmaceutical IND003000 · KOSPI	₩3,670	−0.81%	₩953M	₩362B	0.68%
Curocell372320 · KOSDAQ	₩23,050	−2.74%	₩514M	₩351B	0.46%
Orum Therapeutics475830 · KOSDAQ	₩15,320	−3.10%	₩2.5B	₩333B	0.09%
Dong-A ST170900 · KOSPI	₩33,850	−0.44%	₩502M	₩329B	4.78%
AprilBio397030 · KOSDAQ	₩11,810	−4.76%	₩3B	₩325B	0.95%
Medipostco078160 · KOSDAQ	₩8,090	−3.11%	₩485M	₩317B	1.55%
Samyang Biopharm0120G0 · KOSPI	₩38,650	−5.50%	₩1.4B	₩287B	1.73%
ToolGen199800 · KOSDAQ	₩29,200	−5.65%	₩1.1B	₩285B	0.43%
EuBiologics206650 · KOSDAQ	₩7,730	−0.90%	₩598M	₩281B	0.17%
SillaJen215600 · KOSDAQ	₩2,020	−1.94%	₩871M	₩280B	0.09%
NKGen Biotech Korea182400 · KOSDAQ	₩3,670	0.00%	₩0	₩265B	—
Q AID377460 · KOSDAQ	₩4,080	0.00%	₩0	₩253B	—
Genomictree228760 · KOSDAQ	₩9,970	+0.71%	₩580M	₩248B	0.51%
Prestige BioPharma950210 · KOSPI	₩4,020	−3.25%	₩349M	₩242B	0.15%
S.Biomedics304360 · KOSDAQ	₩19,190	−2.09%	₩468M	₩240B	—
HLB Therapeutics115450 · KOSDAQ	₩2,495	−2.54%	₩1.7B	₩236B	0.10%
ImmuneOncia Therapeutics424870 · KOSDAQ	₩2,515	−3.27%	₩925M	₩230B	—
IntoCell287840 · KOSDAQ	₩14,890	−4.12%	₩275M	₩224B	1.04%
GC Genome340450 · KOSDAQ	₩9,100	+6.06%	₩22B	₩215B	—
FutureChem220100 · KOSDAQ	₩6,930	−7.35%	₩1.6B	₩215B	0.76%
BioPlus099430 · KOSDAQ	₩3,200	−6.16%	₩528M	₩197B	0.42%
Binex053030 · KOSDAQ	₩6,030	−0.82%	₩446M	₩197B	2.17%
Genome&Company314130 · KOSDAQ	₩3,505	−3.71%	₩773M	₩188B	0.24%
Vivozon Pharmaceutical082800 · KOSDAQ	₩3,095	+5.45%	₩792M	₩188B	—
curacle365270 · KOSDAQ	₩7,950	−0.87%	₩122M	₩176B	0.50%
Kangstem Biotech217730 · KOSDAQ	₩1,872	−1.42%	₩598M	₩176B	0.10%
Bioneercorporation064550 · KOSDAQ	₩6,810	−2.44%	₩927M	₩176B	0.10%
DuChemBio176750 · KOSDAQ	₩6,090	−4.84%	₩1.2B	₩173B	0.04%
Helixmith084990 · KOSDAQ	₩3,700	+2.21%	₩493M	₩171B	0.12%
3billion394800 · KOSDAQ	₩5,350	−13.01%	₩3.4B	₩170B	4.02%
Eone Diagnomics Genome Center245620 · KOSDAQ	₩741	0.00%	₩0	₩167B	—
Kolon Life Science102940 · KOSDAQ	₩12,410	−3.27%	₩784M	₩162B	0.50%
BNC Korea256840 · KOSDAQ	₩2,350	−3.29%	₩1B	₩161B	—
GC Cell144510 · KOSDAQ	₩10,100	+3.59%	₩728M	₩160B	0.06%
Cellbion308430 · KOSDAQ	₩11,670	−8.25%	₩220M	₩151B	—
Aptabio Therapeutics293780 · KOSDAQ	₩5,090	−4.14%	₩358M	₩143B	0.05%
ISU Abxis086890 · KOSDAQ	₩3,435	−1.58%	₩201M	₩140B	0.20%
Bio Solution086820 · KOSDAQ	₩5,370	−1.65%	₩194M	₩139B	0.15%
Cell Biotech049960 · KOSDAQ	₩14,800	0.00%	₩71M	₩139B	0.00%
Aribio Holdings290690 · KOSDAQ	₩2,620	−2.42%	₩634M	₩139B	—
Y-Biologics338840 · KOSDAQ	₩8,950	−3.24%	₩623M	₩138B	0.17%
Anterogen065660 · KOSDAQ	₩13,360	−5.11%	₩556M	₩134B	0.30%
Ilyang Pharmaceutical007570 · KOSPI	₩6,960	+0.72%	₩96M	₩133B	0.43%
Ensol Biosciences140610 · KONEX	₩8,840	−3.70%	₩16M	₩127B	—
JW Shinyak067290 · KOSDAQ	₩2,220	−3.48%	₩2.6B	₩124B	—
Kanaph Therapeutics0082N0 · KOSDAQ	₩9,100	−5.70%	₩599M	₩121B	—
Macrogen038290 · KOSDAQ	₩10,900	−0.46%	₩115M	₩118B	4.56%
TiumBio321550 · KOSDAQ	₩3,635	−2.15%	₩863M	₩109B	0.31%
MedPacto235980 · KOSDAQ	₩3,050	+2.69%	₩306M	₩105B	2.96%
Celemics331920 · KOSDAQ	₩9,230	+0.11%	₩792M	₩103B	—
Keeps Biopharma256940 · KOSDAQ	₩5,100	−3.95%	₩239M	₩102B	—
Asta246720 · KOSDAQ	₩6,070	0.00%	₩0	₩99B	—
Genexine095700 · KOSDAQ	₩2,160	−0.23%	₩318M	₩98B	0.15%
DreamCIS223250 · KOSDAQ	₩3,990	−0.25%	₩1.4B	₩98B	—
Aribiolab261780 · KOSDAQ	₩3,350	+0.15%	₩661M	₩97B	—
ViGenCell308080 · KOSDAQ	₩4,655	−4.41%	₩399M	₩95B	0.59%
HLB bioStep278650 · KOSDAQ	₩5,290	+0.76%	₩9.5B	₩92B	—
Aminologics074430 · KOSDAQ	₩1,009	+0.90%	₩85M	₩90B	—
HLB Global003580 · KOSPI	₩1,742	+0.58%	₩780M	₩88B	0.29%
T&R Biofab246710 · KOSDAQ	₩1,820	−3.04%	₩522M	₩87B	0.95%
Vaxcell-Bio Therapeutics323990 · KOSDAQ	₩3,725	−1.72%	₩211M	₩87B	0.07%
Corestemchemon166480 · KOSDAQ	₩1,636	−1.45%	₩91M	₩86B	0.02%
iNtRON Biotechnology048530 · KOSDAQ	₩2,790	−2.96%	₩375M	₩86B	1.38%
Cellumed049180 · KOSDAQ	₩1,009	0.00%	₩0	₩84B	—
Enzychem Lifesciences183490 · KOSDAQ	₩990	0.00%	₩0	₩84B	0.30%
Choong ANG Vaccine Laboratory072020 · KOSDAQ	₩8,810	−0.68%	₩72M	₩82B	—
HLB Genex187420 · KOSDAQ	₩2,360	+4.66%	₩625M	₩77B	—
SCL Science246960 · KOSDAQ	₩2,140	−3.17%	₩373M	₩74B	—
GC Medical Science142280 · KOSDAQ	₩3,085	−2.37%	₩1.6B	₩74B	—
Eye Gene185490 · KOSDAQ	₩1,705	−2.57%	₩69M	₩74B	2.40%
Yuhan Pref.000105 · KOSPI	₩64,000	+0.47%	₩34M	₩73B	—
Theragen Etex066700 · KOSDAQ	₩1,980	+0.25%	₩60M	₩73B	0.40%
Daebonglsco078140 · KOSDAQ	₩6,550	−1.36%	₩79M	₩73B	2.30%
Choolip & Sciences291650 · KOSDAQ	₩2,375	+3.26%	₩78M	₩72B	—
Pharos iBio388870 · KOSDAQ	₩5,580	−3.46%	₩153M	₩72B	—
Sugentech253840 · KOSDAQ	₩4,060	−0.61%	₩179M	₩68B	—
DongKook Life Science303810 · KOSDAQ	₩2,095	−2.33%	₩508M	₩67B	—
Amicogen092040 · KOSDAQ	₩916	+1.10%	₩349M	₩65B	0.37%
CG Invites083790 · KOSDAQ	₩841	−4.10%	₩106M	₩65B	—
SunBio067370 · KOSDAQ	₩5,250	−5.06%	₩14M	₩64B	—
PharmGen Science004720 · KOSPI	₩2,765	+0.55%	₩57M	₩63B	0.08%
Inventera0007J0 · KOSDAQ	₩7,920	−5.04%	₩419M	₩62B	—
Optipharm153710 · KOSDAQ	₩4,245	−2.30%	₩34M	₩62B	0.44%
Abion203400 · KOSDAQ	₩3,380	0.00%	₩0	₩61B	0.98%
Adbiotech179530 · KOSDAQ	₩1,886	−2.28%	₩50M	₩59B	—
Pangen Biotech222110 · KOSDAQ	₩4,285	−7.05%	₩92M	₩58B	—
HLB Panagene046210 · KOSDAQ	₩1,259	−0.47%	₩291M	₩57B	—
Tego Science191420 · KOSDAQ	₩7,040	−3.03%	₩8.1M	₩57B	—
HL Genomics0156T0 · KOSDAQ	₩7,000	−1.69%	₩229M	₩54B	—
NeoImmuneTech950220 · KOSDAQ	₩1,576	−3.43%	₩199M	₩54B	—
Cytogen217330 · KOSDAQ	₩2,315	−1.28%	₩125M	₩54B	—
KoBioLabs348150 · KOSDAQ	₩2,670	−1.84%	₩27M	₩52B	—
ENCell456070 · KOSDAQ	₩4,675	−3.81%	₩198M	₩52B	—
NovMetaPharma229500 · KONEX	₩3,880	+14.96%	₩83M	₩50B	—
GeneOne Life Science011000 · KOSPI	₩2,670	0.00%	₩0	₩49B	0.19%
Epi Biotech446440 · KONEX	₩21,000	−2.33%	₩313,900	₩48B	—
CJ Bioscience311690 · KOSDAQ	₩3,695	+0.14%	₩11M	₩48B	—
Aprogen007460 · KOSPI	₩1,870	−1.42%	₩249M	₩48B	0.76%
QuadMedicine464490 · KOSDAQ	₩4,150	+0.61%	₩142M	₩48B	—
Geninus389030 · KOSDAQ	₩1,183	−5.36%	₩625M	₩47B	—
Inbiogen101140 · KOSPI	₩4,605	0.00%	₩2.7M	₩46B	0.01%
Gencurix229000 · KOSDAQ	₩1,957	0.00%	₩0	₩46B	0.81%
Quratis348080 · KOSDAQ	₩3,515	0.00%	₩49M	₩45B	—
RPbio314140 · KOSDAQ	₩5,080	−3.24%	₩20M	₩44B	—
Aprogen Biologics003060 · KOSPI	₩1,335	−3.26%	₩125M	₩40B	0.08%
Green Lifescience114450 · KOSDAQ	₩1,990	−1.97%	₩209M	₩40B	—
Wonbiogen307280 · KOSDAQ	₩5,500	−2.14%	₩103M	₩39B	—
Oncocross382150 · KOSDAQ	₩2,875	−5.12%	₩135M	₩38B	—
HLB Pep196300 · KOSDAQ	₩3,810	−6.27%	₩65M	₩36B	—
Kainos Medicine284620 · KOSDAQ	₩1,087	0.00%	₩0	₩36B	—
Organoidsciences476040 · KOSDAQ	₩5,460	−3.87%	₩89M	₩36B	1.38%
Eutilex263050 · KOSDAQ	₩959	0.00%	₩0	₩35B	0.74%
Orientbio002630 · KOSPI	₩1,190	−3.17%	₩38M	₩35B	0.06%
Kolmar BioTech215380 · KOSDAQ	₩2,045	−3.76%	₩48M	₩34B	—
SeouLin Bioscience038070 · KOSDAQ	₩3,565	−1.11%	₩26M	₩33B	—
Genolution225220 · KOSDAQ	₩1,724	+0.23%	₩105M	₩33B	—
Hass450330 · KOSDAQ	₩3,975	−2.69%	₩11M	₩33B	—
Biotoxtech086040 · KOSDAQ	₩1,999	−1.53%	₩28M	₩32B	—
LabGenomics084650 · KOSDAQ	₩2,095	+4.23%	₩94M	₩31B	0.58%
ProGen296160 · KONEX	₩2,020	−0.98%	₩4.9M	₩31B	—
SLSBio(Specialty Lab Solution Bio)246250 · KOSDAQ	₩1,969	0.00%	₩0	₩30B	—
Genematrix109820 · KOSDAQ	₩1,403	−1.13%	₩63M	₩29B	—
C&R Research359090 · KOSDAQ	₩2,120	−4.29%	₩7.5M	₩24B	—
GFC Life Science388610 · KOSDAQ	₩4,275	−3.82%	₩76M	₩23B	—
Daesung Microbiological Labs036480 · KOSDAQ	₩5,490	−0.54%	₩7.4M	₩21B	—
MFC432980 · KOSDAQ	₩2,245	−1.97%	₩6.4M	₩19B	—
WooGene B&Gco018620 · KOSDAQ	₩2,760	−4.33%	₩48M	₩19B	—
Plumbline Life Sciences222670 · KONEX	₩4,635	0.00%	₩0	₩19B	—
Jeonjinbio110020 · KOSDAQ	₩2,050	0.00%	₩17M	₩19B	—
Moogene Medi322970 · KONEX	₩1,796	−2.66%	₩3M	₩18B	—
Xcell Therapeutics373110 · KOSDAQ	₩973	−2.51%	₩24M	₩17B	—
PeopleBio304840 · KOSDAQ	₩561	0.00%	₩0	₩14B	—
Celestra352770 · KOSDAQ	₩5,250	0.00%	₩0	₩14B	—
Olipass244460 · KOSDAQ	₩1,651	0.00%	₩0	₩13B	—
Curachem456190 · KONEX	₩7,210	0.00%	₩0	₩13B	—
Invites Biocore216400 · KONEX	₩1,389	−0.79%	₩204,026	₩11B	—
From Bio377220 · KOSDAQ	₩1,760	−6.48%	₩85M	₩10B	—
Median Diagnostics233250 · KONEX	₩4,800	0.00%	₩0	₩8.4B	—
BioInfra199730 · KOSDAQ	₩1,350	−0.88%	₩298M	₩6.6B	—
MOA Life Plus142760 · KOSDAQ	₩220	−6.78%	₩202M	₩4.6B	—
Cronex215570 · KONEX	₩600	+0.33%	₩121,210	₩4B	—
BioInfra Life Science266470 · KONEX	₩104	+5.05%	₩28,043	₩2.9B	—

Source: KRX statistical information